CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Crinetics Pharmaceuticals Inc Company Snapshot
Crinetics Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Crinetics Pharmaceuticals Inc with three other companies in this sector in the United States: Liquidia Technologies Inc (2018 sales of $2.71 million ), Xeris Pharmaceuticals Inc ($2.47 million of which 100% was Commercial physical), and Ardelyx Inc ($2.61 million of which 100% was Development of Biopharmaceutical Product).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Crinetics Pharmaceuticals Inc
  Stock Performance Chart for Crinetics Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 16.48
(Figures in U.S. Dollars)
1 Week -0.7%   13 Weeks -3.3%  
4 Weeks -31.6%   52 Weeks -31.1%  
 
Crinetics Pharmaceuticals Inc Key Data:
  Ticker: CRNX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 2,428,000
(Year Ending Jan 2019).
Employees: 49
  Currency: U.S. Dollars Market Cap: 398,733,600
  Fiscal Yr Ends: December Shares Outstanding: 24,195,000
  Share Type: Common Closely Held Shares: 1,360,709
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.